FDA approves new multiple sclerosis treatment Aubagio

Ok this is not directly related to stroke  but a previous MS drug -

Dalfampridine -

showed promise in Stroke rehab, so ask our researchers if myelin repair is needed in our white matter after a stroke.
http://www.cbsnews.com/8301-504763_162-57512454-10391704/fda-approves-new-multiple-sclerosis-treatment-aubagio/
There are a few side effects so beware;
People taking Aubagio may experience diarrhea, abnormal liver tests, nausea, and hair loss, and there is a boxed warning that describes an increased risk of liver problems, including death, and a risk of birth defects. Tests on animals have shown that it may cause fetal harm, so patients cannot be pregnant while on the tablet.The FDA recommends that doctors perform a blood test to check liver function before putting patient on the medication.